CN Stock MarketDetailed Quotes

688185 CanSino Biologics Inc.

Watchlist
  • 61.47
  • -2.49-3.89%
Trading Nov 18 14:45 CST
15.21BMarket Cap-21123P/E (TTM)

CanSino Biologics Inc. Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Assets
Current assets
Money funds
-57.64%1.36B
-33.50%1.99B
-25.25%2.58B
-18.56%2.82B
8.49%3.22B
-20.31%2.99B
-19.45%3.46B
-38.62%3.46B
-42.22%2.97B
-21.08%3.76B
Transactional financial assets
71.19%1.92B
12.56%1.55B
-25.62%1.43B
-47.29%1.31B
-67.54%1.12B
-57.63%1.38B
-24.58%1.92B
33.27%2.48B
73.90%3.45B
66.47%3.25B
Notes receivable and accounts receivable
3.84%678.06M
-33.92%578.12M
-31.42%595.13M
-25.55%636.88M
109.28%652.97M
177.01%874.87M
147.58%867.84M
441.70%855.49M
-35.21%312.01M
-54.68%315.83M
-Accounts receivable
3.84%678.06M
-33.92%578.12M
-31.42%595.13M
-25.55%636.88M
109.28%652.97M
177.01%874.87M
147.58%867.84M
441.70%855.49M
-35.21%312.01M
-54.68%315.83M
Other receivables (including interest and dividends)
20.11%9.27M
45.44%8.76M
197.68%10.32M
12.45%5.72M
-67.89%7.71M
18.75%6.03M
-26.31%3.47M
-73.46%5.08M
255.59%24.03M
306.78%5.07M
-Other receivable
----
45.44%8.76M
----
12.45%5.72M
----
18.75%6.03M
----
-73.46%5.08M
----
306.78%5.07M
Advance payment
-35.47%51.09M
-45.36%48M
-67.65%45.12M
-59.84%48.55M
-77.05%79.16M
-75.74%87.85M
-68.85%139.49M
-68.07%120.89M
4.86%344.9M
36.32%362.15M
Inventories
-17.32%345.07M
-20.68%360.48M
-54.92%355.42M
-47.94%352.85M
-52.60%417.38M
-61.76%454.44M
-29.72%788.35M
-22.59%677.78M
49.21%880.46M
129.60%1.19B
Non-current assets due within one year
----
--165.55K
----
----
----
----
----
----
----
----
Other current assets
-90.59%2.62M
-98.20%2.43M
-98.40%2.25M
-95.43%5.67M
-74.77%27.87M
7.84%134.8M
81.29%140.96M
64.04%124.16M
191.81%110.47M
246.66%124.99M
Total current assets
-20.95%4.37B
-23.44%4.54B
-31.37%5.02B
-32.98%5.18B
-31.72%5.53B
-34.15%5.93B
-19.75%7.32B
-16.79%7.73B
-5.55%8.09B
9.40%9B
Non Current assets
Other non-current financial assets
-2.84%148.66M
6.67%148.54M
189.65%150.23M
160.63%122.15M
237.66%153M
207.34%139.26M
14.47%51.87M
3.43%46.87M
53.07%45.31M
53.07%45.31M
Fixed assets
----
9.07%1.42B
----
13.00%1.7B
----
8.53%1.3B
----
30.32%1.5B
----
37.15%1.2B
Constru in process
----
-23.49%1.02B
----
-17.02%1.11B
----
25.72%1.33B
----
63.50%1.34B
----
105.15%1.06B
Intangible assets
-37.49%119.16M
-41.16%118.78M
-40.74%126.34M
-34.75%144.15M
-13.02%190.63M
6.55%201.85M
26.63%213.21M
28.36%220.92M
90.19%219.17M
199.74%189.45M
Development expenditure
159.35%145.49M
218.44%123.94M
128.88%89.08M
62.63%61.5M
70.61%56.1M
36.80%38.92M
36.80%38.92M
44.39%37.81M
-16.48%32.88M
-19.10%28.45M
Long deferred expense
-16.85%22.75M
-16.37%24.15M
92.94%25.47M
90.25%26.9M
53.08%27.37M
399.34%28.87M
247.94%13.2M
--14.14M
-9.71%17.88M
-75.41%5.78M
Deferred tax assets
4.46%206.38M
4.79%207.03M
-8.30%207.86M
5.83%207.86M
36.65%197.57M
468.33%197.57M
--226.68M
--196.41M
232.34%144.59M
-65.34%34.76M
Usufruct assets
-91.47%17.68M
-90.83%19.6M
-90.36%21.16M
-10.04%202.01M
-10.34%207.33M
-9.76%213.64M
-8.85%219.51M
-8.19%224.55M
7.79%231.25M
15.69%236.74M
Other non current assets
-11.62%469.77M
-2.77%494.41M
148.07%535.55M
261.63%543.77M
66.91%531.55M
176.50%508.48M
6.92%215.89M
22.83%150.37M
70.26%318.47M
6.96%183.9M
Total non current assets
-11.34%3.62B
-9.40%3.6B
-8.99%3.54B
10.68%4.14B
18.53%4.08B
32.91%3.97B
38.53%3.89B
44.67%3.74B
48.80%3.45B
47.67%2.99B
Total assets
-16.87%7.99B
-17.81%8.13B
-23.60%8.57B
-18.75%9.32B
-16.71%9.61B
-17.45%9.9B
-6.02%11.22B
-3.41%11.47B
6.01%11.54B
16.95%11.99B
Liabilities
Current liabilities
Short term loan
-28.11%596.88M
-19.51%689.64M
-27.73%955.02M
-44.17%854.08M
-46.33%830.23M
-42.49%856.83M
22.45%1.32B
54.42%1.53B
81.86%1.55B
156.19%1.49B
Notes payable and accounts payable
-52.40%72.54M
-58.61%77.83M
-70.94%72.45M
-58.92%103.97M
-65.62%152.39M
-61.77%188.05M
-73.05%249.31M
-69.96%253.12M
-27.72%443.27M
1.43%491.96M
-Notes payable
----
----
----
----
344.09%22.2M
-41.69%27.2M
-29.49%32.9M
--32.9M
--5M
--46.65M
-Accounts payable
-44.28%72.54M
-51.61%77.83M
-66.52%72.45M
-52.79%103.97M
-70.30%130.18M
-63.88%160.85M
-75.37%216.41M
-73.86%220.22M
-28.53%438.27M
-8.19%445.3M
Contract liabilities
424.35%10.99M
77.08%1.27M
999.38%10.83M
140.98%3.57M
-67.28%2.1M
-96.59%715.04K
-95.84%985K
-99.23%1.48M
-98.20%6.41M
-95.31%20.96M
Salaries payable
-56.89%41.94M
-50.60%51.63M
-30.55%132.39M
-8.61%166.71M
-38.65%97.28M
-34.55%104.52M
20.55%190.63M
-18.10%182.41M
1.62%158.56M
31.63%159.69M
Taxs payable
388.62%23.9M
301.45%30.5M
349.95%37.37M
103.21%48.2M
6.19%4.89M
119.57%7.6M
-73.18%8.31M
-31.32%23.72M
6.74%4.61M
-22.10%3.46M
Other payable (including interest and dividends)
-29.54%427.32M
-22.14%462.53M
-6.71%484.84M
14.99%673.58M
11.73%606.48M
-18.11%594.05M
8.30%519.71M
28.34%585.76M
31.75%542.79M
43.97%725.44M
-Interest payable
----
----
----
--310.65K
----
----
----
----
----
----
-Dividend payable
----
----
----
----
----
----
----
----
--3.63M
--197.56M
-Other payable
----
-22.14%462.53M
----
14.94%673.27M
----
12.54%594.05M
----
28.34%585.76M
----
4.76%527.88M
Non current liabilities due within one year
-9.49%531.95M
-9.56%513.09M
228.55%322.11M
508.51%575.22M
770.16%587.7M
427.84%567.35M
26.69%98.04M
-22.06%94.53M
-42.78%67.54M
28.48%107.49M
Other current liabilities
-61.85%65.2M
-85.23%58.63M
-62.04%87.73M
-45.25%139M
--170.88M
--397.05M
--231.09M
--253.89M
----
----
Total current liabilities
-28.14%1.77B
-30.60%1.89B
-19.75%2.1B
-12.29%2.57B
-11.00%2.47B
-9.43%2.72B
-5.56%2.62B
2.21%2.92B
-10.40%2.77B
6.42%3B
Current liabilities
Long term deferred income
-15.79%181.08M
-15.05%186.99M
-14.26%188.25M
-2.54%216.72M
2.77%215.03M
12.69%220.12M
10.70%219.55M
10.36%222.35M
23.19%209.23M
11.51%195.34M
Lease liabilities
-93.62%11.35M
-93.55%11.99M
-93.09%13.78M
-11.65%175.18M
-11.78%177.93M
-11.81%186.03M
-10.58%199.29M
-11.02%198.29M
-0.89%201.7M
7.12%210.95M
Other non current liabilities
----
----
--8.49M
--8.49M
--8.49M
--8.49M
----
----
----
----
Total non current liabilities
-14.28%1.15B
-1.81%1.19B
-10.40%1.36B
12.89%1.47B
32.82%1.35B
65.25%1.21B
161.87%1.52B
179.35%1.3B
171.62%1.01B
75.82%733.34M
Total liabilities
-23.25%2.93B
-21.72%3.08B
-16.32%3.46B
-4.55%4.03B
0.74%3.81B
5.25%3.93B
23.36%4.14B
26.97%4.22B
9.21%3.78B
15.36%3.73B
Shareholders equity
Paid-in capital
0.00%247.45M
0.00%247.45M
-0.00%247.45M
0.00%247.45M
-0.00%247.45M
-0.00%247.45M
0.00%247.45M
-0.00%247.45M
0.00%247.45M
0.00%247.45M
Capital reserve funds
0.07%6.58B
0.10%6.58B
-0.54%6.58B
-0.52%6.57B
-0.51%6.57B
-0.49%6.57B
0.15%6.61B
0.15%6.61B
0.02%6.61B
0.09%6.6B
Surplus reserve funds
0.00%118.39M
0.00%118.39M
-0.00%118.39M
0.00%118.39M
-0.00%118.39M
-0.00%118.39M
0.00%118.39M
-0.00%118.39M
--118.39M
--118.39M
Retained profit
-67.89%-1.78B
-94.50%-1.78B
-703.10%-1.73B
-1,959.17%-1.56B
-395.18%-1.06B
-208.41%-917.11M
-118.67%-215.23M
-107.34%-75.68M
-36.87%359.34M
390.60%845.99M
Less:Treasury stock
-7.59%98.11M
-6.96%98.79M
-29.30%106.17M
-29.30%106.17M
-6.76%106.17M
-6.76%106.17M
76.87%150.17M
--150.17M
--113.88M
--113.88M
Other composite income
-15.92%204.61K
19.05%319.43K
-4.77%146.65K
-246.14%-176.15K
334.55%243.35K
--268.31K
--154K
--120.53K
--56K
----
Shareholders equity without minority interests
-12.26%5.06B
-14.43%5.06B
-22.76%5.11B
-21.84%5.27B
-20.04%5.77B
-23.22%5.91B
-17.72%6.61B
-15.60%6.75B
-2.74%7.22B
9.75%7.7B
Minority interests
----
----
----
-97.42%12.81M
-94.87%27.62M
-89.80%56.77M
-14.45%466.86M
-10.01%497.51M
--538.57M
--556.64M
Total shareholder equity
-12.67%5.06B
-15.24%5.06B
-27.85%5.11B
-27.03%5.29B
-25.23%5.8B
-27.71%5.97B
-17.51%7.08B
-15.24%7.25B
4.51%7.76B
17.68%8.26B
Total liabilityies and equity
-16.87%7.99B
-17.81%8.13B
-23.60%8.57B
-18.75%9.32B
-16.71%9.61B
-17.45%9.9B
-6.02%11.22B
-3.41%11.47B
6.01%11.54B
16.95%11.99B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Deloitte Huayong Certified Public Accountants (Special General Partnership)
--
--
--
Deloitte Huayong Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Assets
Current assets
Money funds -57.64%1.36B-33.50%1.99B-25.25%2.58B-18.56%2.82B8.49%3.22B-20.31%2.99B-19.45%3.46B-38.62%3.46B-42.22%2.97B-21.08%3.76B
Transactional financial assets 71.19%1.92B12.56%1.55B-25.62%1.43B-47.29%1.31B-67.54%1.12B-57.63%1.38B-24.58%1.92B33.27%2.48B73.90%3.45B66.47%3.25B
Notes receivable and accounts receivable 3.84%678.06M-33.92%578.12M-31.42%595.13M-25.55%636.88M109.28%652.97M177.01%874.87M147.58%867.84M441.70%855.49M-35.21%312.01M-54.68%315.83M
-Accounts receivable 3.84%678.06M-33.92%578.12M-31.42%595.13M-25.55%636.88M109.28%652.97M177.01%874.87M147.58%867.84M441.70%855.49M-35.21%312.01M-54.68%315.83M
Other receivables (including interest and dividends) 20.11%9.27M45.44%8.76M197.68%10.32M12.45%5.72M-67.89%7.71M18.75%6.03M-26.31%3.47M-73.46%5.08M255.59%24.03M306.78%5.07M
-Other receivable ----45.44%8.76M----12.45%5.72M----18.75%6.03M-----73.46%5.08M----306.78%5.07M
Advance payment -35.47%51.09M-45.36%48M-67.65%45.12M-59.84%48.55M-77.05%79.16M-75.74%87.85M-68.85%139.49M-68.07%120.89M4.86%344.9M36.32%362.15M
Inventories -17.32%345.07M-20.68%360.48M-54.92%355.42M-47.94%352.85M-52.60%417.38M-61.76%454.44M-29.72%788.35M-22.59%677.78M49.21%880.46M129.60%1.19B
Non-current assets due within one year ------165.55K--------------------------------
Other current assets -90.59%2.62M-98.20%2.43M-98.40%2.25M-95.43%5.67M-74.77%27.87M7.84%134.8M81.29%140.96M64.04%124.16M191.81%110.47M246.66%124.99M
Total current assets -20.95%4.37B-23.44%4.54B-31.37%5.02B-32.98%5.18B-31.72%5.53B-34.15%5.93B-19.75%7.32B-16.79%7.73B-5.55%8.09B9.40%9B
Non Current assets
Other non-current financial assets -2.84%148.66M6.67%148.54M189.65%150.23M160.63%122.15M237.66%153M207.34%139.26M14.47%51.87M3.43%46.87M53.07%45.31M53.07%45.31M
Fixed assets ----9.07%1.42B----13.00%1.7B----8.53%1.3B----30.32%1.5B----37.15%1.2B
Constru in process -----23.49%1.02B-----17.02%1.11B----25.72%1.33B----63.50%1.34B----105.15%1.06B
Intangible assets -37.49%119.16M-41.16%118.78M-40.74%126.34M-34.75%144.15M-13.02%190.63M6.55%201.85M26.63%213.21M28.36%220.92M90.19%219.17M199.74%189.45M
Development expenditure 159.35%145.49M218.44%123.94M128.88%89.08M62.63%61.5M70.61%56.1M36.80%38.92M36.80%38.92M44.39%37.81M-16.48%32.88M-19.10%28.45M
Long deferred expense -16.85%22.75M-16.37%24.15M92.94%25.47M90.25%26.9M53.08%27.37M399.34%28.87M247.94%13.2M--14.14M-9.71%17.88M-75.41%5.78M
Deferred tax assets 4.46%206.38M4.79%207.03M-8.30%207.86M5.83%207.86M36.65%197.57M468.33%197.57M--226.68M--196.41M232.34%144.59M-65.34%34.76M
Usufruct assets -91.47%17.68M-90.83%19.6M-90.36%21.16M-10.04%202.01M-10.34%207.33M-9.76%213.64M-8.85%219.51M-8.19%224.55M7.79%231.25M15.69%236.74M
Other non current assets -11.62%469.77M-2.77%494.41M148.07%535.55M261.63%543.77M66.91%531.55M176.50%508.48M6.92%215.89M22.83%150.37M70.26%318.47M6.96%183.9M
Total non current assets -11.34%3.62B-9.40%3.6B-8.99%3.54B10.68%4.14B18.53%4.08B32.91%3.97B38.53%3.89B44.67%3.74B48.80%3.45B47.67%2.99B
Total assets -16.87%7.99B-17.81%8.13B-23.60%8.57B-18.75%9.32B-16.71%9.61B-17.45%9.9B-6.02%11.22B-3.41%11.47B6.01%11.54B16.95%11.99B
Liabilities
Current liabilities
Short term loan -28.11%596.88M-19.51%689.64M-27.73%955.02M-44.17%854.08M-46.33%830.23M-42.49%856.83M22.45%1.32B54.42%1.53B81.86%1.55B156.19%1.49B
Notes payable and accounts payable -52.40%72.54M-58.61%77.83M-70.94%72.45M-58.92%103.97M-65.62%152.39M-61.77%188.05M-73.05%249.31M-69.96%253.12M-27.72%443.27M1.43%491.96M
-Notes payable ----------------344.09%22.2M-41.69%27.2M-29.49%32.9M--32.9M--5M--46.65M
-Accounts payable -44.28%72.54M-51.61%77.83M-66.52%72.45M-52.79%103.97M-70.30%130.18M-63.88%160.85M-75.37%216.41M-73.86%220.22M-28.53%438.27M-8.19%445.3M
Contract liabilities 424.35%10.99M77.08%1.27M999.38%10.83M140.98%3.57M-67.28%2.1M-96.59%715.04K-95.84%985K-99.23%1.48M-98.20%6.41M-95.31%20.96M
Salaries payable -56.89%41.94M-50.60%51.63M-30.55%132.39M-8.61%166.71M-38.65%97.28M-34.55%104.52M20.55%190.63M-18.10%182.41M1.62%158.56M31.63%159.69M
Taxs payable 388.62%23.9M301.45%30.5M349.95%37.37M103.21%48.2M6.19%4.89M119.57%7.6M-73.18%8.31M-31.32%23.72M6.74%4.61M-22.10%3.46M
Other payable (including interest and dividends) -29.54%427.32M-22.14%462.53M-6.71%484.84M14.99%673.58M11.73%606.48M-18.11%594.05M8.30%519.71M28.34%585.76M31.75%542.79M43.97%725.44M
-Interest payable --------------310.65K------------------------
-Dividend payable ----------------------------------3.63M--197.56M
-Other payable -----22.14%462.53M----14.94%673.27M----12.54%594.05M----28.34%585.76M----4.76%527.88M
Non current liabilities due within one year -9.49%531.95M-9.56%513.09M228.55%322.11M508.51%575.22M770.16%587.7M427.84%567.35M26.69%98.04M-22.06%94.53M-42.78%67.54M28.48%107.49M
Other current liabilities -61.85%65.2M-85.23%58.63M-62.04%87.73M-45.25%139M--170.88M--397.05M--231.09M--253.89M--------
Total current liabilities -28.14%1.77B-30.60%1.89B-19.75%2.1B-12.29%2.57B-11.00%2.47B-9.43%2.72B-5.56%2.62B2.21%2.92B-10.40%2.77B6.42%3B
Current liabilities
Long term deferred income -15.79%181.08M-15.05%186.99M-14.26%188.25M-2.54%216.72M2.77%215.03M12.69%220.12M10.70%219.55M10.36%222.35M23.19%209.23M11.51%195.34M
Lease liabilities -93.62%11.35M-93.55%11.99M-93.09%13.78M-11.65%175.18M-11.78%177.93M-11.81%186.03M-10.58%199.29M-11.02%198.29M-0.89%201.7M7.12%210.95M
Other non current liabilities ----------8.49M--8.49M--8.49M--8.49M----------------
Total non current liabilities -14.28%1.15B-1.81%1.19B-10.40%1.36B12.89%1.47B32.82%1.35B65.25%1.21B161.87%1.52B179.35%1.3B171.62%1.01B75.82%733.34M
Total liabilities -23.25%2.93B-21.72%3.08B-16.32%3.46B-4.55%4.03B0.74%3.81B5.25%3.93B23.36%4.14B26.97%4.22B9.21%3.78B15.36%3.73B
Shareholders equity
Paid-in capital 0.00%247.45M0.00%247.45M-0.00%247.45M0.00%247.45M-0.00%247.45M-0.00%247.45M0.00%247.45M-0.00%247.45M0.00%247.45M0.00%247.45M
Capital reserve funds 0.07%6.58B0.10%6.58B-0.54%6.58B-0.52%6.57B-0.51%6.57B-0.49%6.57B0.15%6.61B0.15%6.61B0.02%6.61B0.09%6.6B
Surplus reserve funds 0.00%118.39M0.00%118.39M-0.00%118.39M0.00%118.39M-0.00%118.39M-0.00%118.39M0.00%118.39M-0.00%118.39M--118.39M--118.39M
Retained profit -67.89%-1.78B-94.50%-1.78B-703.10%-1.73B-1,959.17%-1.56B-395.18%-1.06B-208.41%-917.11M-118.67%-215.23M-107.34%-75.68M-36.87%359.34M390.60%845.99M
Less:Treasury stock -7.59%98.11M-6.96%98.79M-29.30%106.17M-29.30%106.17M-6.76%106.17M-6.76%106.17M76.87%150.17M--150.17M--113.88M--113.88M
Other composite income -15.92%204.61K19.05%319.43K-4.77%146.65K-246.14%-176.15K334.55%243.35K--268.31K--154K--120.53K--56K----
Shareholders equity without minority interests -12.26%5.06B-14.43%5.06B-22.76%5.11B-21.84%5.27B-20.04%5.77B-23.22%5.91B-17.72%6.61B-15.60%6.75B-2.74%7.22B9.75%7.7B
Minority interests -------------97.42%12.81M-94.87%27.62M-89.80%56.77M-14.45%466.86M-10.01%497.51M--538.57M--556.64M
Total shareholder equity -12.67%5.06B-15.24%5.06B-27.85%5.11B-27.03%5.29B-25.23%5.8B-27.71%5.97B-17.51%7.08B-15.24%7.25B4.51%7.76B17.68%8.26B
Total liabilityies and equity -16.87%7.99B-17.81%8.13B-23.60%8.57B-18.75%9.32B-16.71%9.61B-17.45%9.9B-6.02%11.22B-3.41%11.47B6.01%11.54B16.95%11.99B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Deloitte Huayong Certified Public Accountants (Special General Partnership)------Deloitte Huayong Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data